Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $797.18 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $412.90 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $143.91 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $88.21 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $78.03 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $74.13 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $304.93 | 4 | Novo Nordisk Inc ($163.20) |
| 2017 | $492.25 | 5 | Novo Nordisk Inc ($249.70) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: Diabetes | ||||||
| 06/27/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $41.34 | General |
| Category: Diabetes | ||||||
| 05/01/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $78.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $63.70 | General |
| Category: DIABETES | ||||||
| 12/19/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $88.21 | General |
| Category: DIABETES | ||||||
| 04/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $80.21 | General |
| Category: DIABETES | ||||||
| 03/23/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 02/23/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $124.70 | General |
| Category: Diabetes | ||||||
| 01/18/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $74.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Lanier Stenhouse, M.D
Dr. Lanier Stenhouse, M.D is a General Practice healthcare provider based in Oroville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902983786.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lanier Stenhouse, M.D has received a total of $797.18 in payments from pharmaceutical and medical device companies, with $304.93 received in 2018. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($797.18).
Practice Information
- Specialty General Practice
- Location Oroville, CA
- Active Since 11/01/2006
- Last Updated 03/07/2023
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1902983786
Products in Payments
- Tresiba (Drug) $249.70
- JARDIANCE (Drug) $143.91
- Ozempic (Drug) $121.86
- SOLIQUA (Drug) $88.21
- INVOKANA (Drug) $78.03
- FARXIGA (Drug) $74.13
- Xultophy 100/3.6 (Drug) $41.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Oroville
Jamaal El-Khal, M.d, M.D
General Practice — Payments: $8,993
Dr. Brent Parrott, D.d.s, D.D.S
General Practice — Payments: $3,126
Dr. James Lovelace, Dds, DDS
General Practice — Payments: $599.62
Dr. Robert Winshall, Md, MD
General Practice — Payments: $224.82
Kevin Mckinney
General Practice — Payments: $153.93
Dr. Bryan Wilson, D.d.s, D.D.S
General Practice — Payments: $118.25